Revolune and Propath UK Partner to Enhance Biopharma Workflows

Revolune announced a partnership with Propath UK to expand access to its multiplex immunofluorescence workflow. This collaboration allows researchers to use Revolune's technology in a more flexible manner. By joining Revolune's Service Provider Program, Propath UK offers experienced service-lab execution from its dedicated UK facility.

The partnership aids in the adoption of Revolune's flexible workflow, either through in-house assays or comprehensive services provided by Propath. The offerings include multiplex panel development, imaging, bioinformatics, and GCP-compliant tissue biomarker analysis, ensuring robust support for clinical trials.

Propath UK, with extensive experience in tissue-based biomarker workflows, sees the value in providing Revolune’s technology via a service model. This expands Revolune's reach and assists researchers eager to transition from traditional platforms to more versatile solutions.